Ephedrine supplements label warning against use for weight loss urged by pediatricians.
This article was originally published in The Tan Sheet
Executive Summary
EPHEDRINE LABEL WARNING AGAINST USE FOR WEIGHT LOSS SUGGESTED by the American Academy of Pediatrics in Aug. 15 comments to FDA. Noting the agency has proposed that ephedrine-containing dietary supplements should not be allowed to carry weight loss claims, AAP recommends additional "inclusion of statements advising that such products are not intended for use as an intervention for weight loss." The group supports "full disclosure labeling of such products and oppose[s] any suggestive claims designed to make these products more appealing to children, particularly adolescents."